Risk stratification and management of patients with sustained ventricular tachycardia or ventricular fibrillation.

Sustained ventricular tachycardia and ventricular fibrillation (VT/VF) are lifethreatening threatening arrhythmias. Pharmacological and nonpharmacological therapy of VT/VF
patients are important. In the last decade the role of antiarrhythmic drugs has changed tremendously. In addition, more selective antiarrhythmic drugs became available and nonpharmacological therapy is developing rapidly. As a consequence, reorientation in the evaluation and treatment of VT/VF patients seems appropriate. Therefore, in the University Hospital Groningen a standardized approach of patients with sustained ventricular tachycardia or ventricular fibrillation was started in January 1989 'The Groningen W/W protocol'. This approach focused on identification of underlying heart disease, the risk stratification of VT/VF patients and identification of arrhythmogenic factors. Antiarrhythmic therapy was only initiated in the absence of an evident arrhythmogenic provoking factor. As a rule drug therapy was the first line approach. ...

Zie: Summary

Summary

Meer informatie in de catalogus
Meer informatie in Picarta